On March 20, 2026, Novo Nordisk's patent on semaglutide expired in India, triggering one of the most significant transformations in the country's pharmaceutical history. Within weeks, more than 40 Indian…
🔬 How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide India supplies approximately 20% of the world’s generic medicines by volume, exporting over USD 50 billion…
The Central Drugs Standard Control Organization (CDSCO) is undertaking its most significant regulatory transformation in decades. In a series of reforms announced in early 2026, India's drug regulator has unveiled…
🔬 WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You India supplies approximately 20% of the world's generic medicines by volume, making it the largest…